Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2018, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2018-10-10
DOI
10.1155/2018/4867234
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis
- (2018) Napat Armartmuntree et al. Redox Biology
- An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma
- (2017) Yasuni Nakanuma et al. HUMAN PATHOLOGY
- Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis
- (2017) Shosuke Kawanishi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma
- (2017) Hyungjin Rhee et al. LIVER INTERNATIONAL
- S100P is associated with proliferation and migration in nasopharyngeal carcinoma
- (2017) Yueyang Liu et al. Oncology Letters
- Staging of intrahepatic cholangiocarcinoma
- (2017) Sean M. Ronnekleiv-Kelly et al. HEPATOBILIARY SURGERY AND NUTRITION
- CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment
- (2016) Malinee Thanee et al. CANCER SCIENCE
- Hypoxia-inducible factors: a central link between inflammation and cancer
- (2016) Daniel Triner et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer
- (2016) Keita Kobayashi et al. ONCOLOGY REPORTS
- COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis
- (2016) Mousumi Majumder et al. STEM CELLS
- Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9+ cancer stem cells in ulcerative colitis-related cancer
- (2016) Ryo Seishima et al. Clinics and Research in Hepatology and Gastroenterology
- CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer
- (2016) Se-Il Go et al. Cancer Research and Treatment
- Isolation of All CD44 Transcripts in Human Epidermis and Regulation of Their Expression by Various Agents
- (2016) Kwesi Teye et al. PLoS One
- Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis
- (2015) Shizuka Kiuchi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells
- (2015) Melania E. Mercado-Pimentel et al. FEBS LETTERS
- Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma
- (2015) Zhiliang Wu et al. INTERNATIONAL JOURNAL OF CANCER
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- CD44variant exon 9 plays an important role in colon cancer initiating cells
- (2015) Youhei Kimura et al. Oncotarget
- CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
- (2014) Zhonghu Li et al. Diagnostic Pathology
- Roles of liver fluke infection as risk factor for cholangiocarcinoma
- (2014) Paiboon Sithithaworn et al. Journal of Hepato-Biliary-Pancreatic Sciences
- CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
- (2013) K Hirata et al. BRITISH JOURNAL OF CANCER
- Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia
- (2013) Takeyuki Wada et al. CANCER SCIENCE
- S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer
- (2013) Benjamin Chidi Onyeagucha et al. EXPERIMENTAL CELL RESEARCH
- Redox regulation in stem-like cancer cells by CD44 variant isoforms
- (2013) O Nagano et al. ONCOGENE
- Chronic Cadmium Exposure in Vitro Causes Acquisition of Multiple Tumor Cell Characteristics in Human Pancreatic Epithelial Cells
- (2012) Wei Qu et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Nuclear Localization of COX-2 in relation to the Expression of Stemness Markers in Urinary Bladder Cancer
- (2012) Raynoo Thanan et al. MEDIATORS OF INFLAMMATION
- The induction of S100p expression by the Prostaglandin E2(PGE2)/EP4 receptor signaling pathway in colon cancer cells
- (2011) Anupama Chandramouli et al. CANCER BIOLOGY & THERAPY
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- Hyaluronan-CD44 interactions as potential targets for cancer therapy
- (2011) Suniti Misra et al. FEBS Journal
- Risk factors for cholangiocarcinoma
- (2011) Gia L. Tyson et al. HEPATOLOGY
- Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma
- (2010) Shin Hamada et al. CANCER SCIENCE
- Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties
- (2010) Min Wang et al. INTERNATIONAL JOURNAL OF CANCER
- CD44+slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2in gastric tumorigenesis
- (2009) Takatsugu Ishimoto et al. CANCER SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now